Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene.
about
Sequence variation in human succinate dehydrogenase genes: evidence for long-term balancing selection on SDHASDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paragangliomaDiseases of the adrenal medullaHuman Metabolic Enzymes Deficiency: A Genetic Mutation Based ApproachHeritable Cancer Syndromes Related to the Hypoxia PathwayCombined defects in oxidative phosphorylation and fatty acid β-oxidation in mitochondrial diseasePheochromocytomas and Paragangliomas: Clinical and Genetic ApproachesSuccinate Dehydrogenase Loss in Familial Paraganglioma: Biochemistry, Genetics, and Epigenetics15 YEARS OF PARAGANGLIOMA: Clinical manifestations of paraganglioma syndromes types 1-5Head and neck paragangliomas: clinical and molecular genetic classificationThe genetics of paragangliomas: a reviewCurrent views on cell metabolism in SDHx-related pheochromocytoma and paragangliomaMolecular markers of paragangliomas/pheochromocytomasParagangliomas/Pheochromocytomas: clinically oriented genetic testingThe clinical phenotype of SDHC-associated hereditary paraganglioma syndrome (PGL3).SDH-related pheochromocytoma and paraganglioma.Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility10 rare tumors that warrant a genetics referral.Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations.Mitochondrial targeting of vitamin E succinate enhances its pro-apoptotic and anti-cancer activity via mitochondrial complex IIMalignant head and neck paragangliomas in SDHB mutation carriers.SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromesSuccinate dehydrogenase gene mutations in cardiac paragangliomasClinicoradiological manifestations of paraganglioma syndromes associated with succinyl dehydrogenase enzyme mutation.Paragangliomas and paraganglioma syndromes.Genetic-clinical profile of subjects with apparently sporadic extra-adrenal paragangliomasThe genetic basis of pheochromocytoma and paraganglioma: implications for managementSecondary variants in individuals undergoing exome sequencing: screening of 572 individuals identifies high-penetrance mutations in cancer-susceptibility genes.Phaeochromocytoma: a catecholamine and oxidative stress disorder.A case of co-existing paraganglioma and thymoma.Rare vertebral metastasis in a case of Hereditary Paraganglioma.Clinical aspects of SDHx-related pheochromocytoma and paragangliomaPheochromocytoma and paraganglioma.Aberrant DNA hypermethylation of SDHC: a novel mechanism of tumor development in Carney triad.Tricarboxylic acid cycle dysfunction as a cause of human diseases and tumor formation.Paragangliomas: clinical overview.Clinical use of laboratory tests for the identification of secondary forms of arterial hypertension.Comparison of clinical and imaging features in succinate dehydrogenase-positive versus sporadic paragangliomasPheochromocytoma as a catecholamine producing tumor: implications for clinical practice.Familial carotid body tumours: is there a role for genetic screening?
P2860
Q21245354-5FE6B79C-17D0-496C-B5D7-07871A121433Q24317137-84FD386A-E4E8-4D27-BAE9-478928281015Q24646015-81F2318D-8BE6-4C84-9BCB-5F1B7FE7E896Q26751169-A80A6F0D-6CB9-4A34-974F-BFEC5B9D25F0Q26751590-9192B6EC-20FD-4B14-9746-B0A95B7B3D96Q26770152-37E8A811-BDE1-4E8C-A252-9A0903254909Q26782841-AA778F74-2E06-421C-8575-6CA551DA750AQ26796203-22811C72-66FF-4635-9F00-8E6734001025Q26798384-3B5E32F6-068C-49DA-AFCA-660C84227071Q27016092-C1EC8002-B345-4037-99C3-463B84C1AA91Q28288077-2F34ABAC-8E19-4D6C-9193-A1B1366F20FDQ33590969-795FABF5-291A-4080-B0E8-BDCF71D7ABADQ33649025-47BC111C-CA6C-45AA-BF27-B9FD46FDD2AFQ33679204-99DEA4DA-E1E8-4D6F-AA86-68CBCAB0AD33Q33998937-425AA7F0-2ABA-4F0A-9385-5C2F71ABE17FQ34125978-1ACAE908-CF97-44C9-BD8C-81E1003EB124Q34144574-2694E2DD-2EEC-468C-BB04-9662AEDAAA93Q34325954-82CA40F6-B049-4135-A358-8EA3169DEFB6Q34471702-1C5C884B-EBFF-4E98-8BBD-AFEDE17DAD8FQ34536966-423958CA-9BCE-478B-80DE-FE37D2771AC3Q34643210-ABA21E3C-5081-4C0B-8480-FCECE2AEBC3BQ35185252-435DF992-A828-4B51-9ADB-B58A04E91140Q35668495-008E0A23-A931-4F33-9657-4E169C317E23Q35675637-6F1F7F40-CBB2-428D-9BF7-ACF5853EDB79Q35926265-7DF7724E-69F7-4F6C-AD07-9F505262B160Q36047090-66F85AF4-497B-489A-8B08-9DDA19B466D6Q36067684-8AFA8BBB-7EE7-4304-A22B-4A0674149D98Q36096070-9E2B96B2-FB4A-4919-ABBE-BF317C900F9AQ36149357-ED8C74AD-8653-487B-92EB-41DC0E99777DQ36234153-262CECB9-23D9-4D55-AFCD-A1646D69AC27Q36367439-BDFA00F9-0FCB-4321-AE62-6277D3488856Q36458394-44909895-50D9-4807-92F1-5E6511F1375BQ36467162-9D40311A-C28A-41E9-8F18-09E4BAD798A8Q36489471-B5B1645E-F0F4-4EFC-AB06-6CF052CBA647Q36499636-80CE6C14-4F57-4DF3-93CB-98AF518A9E87Q36652765-E75FA281-7496-44E3-96C0-75CB2533633DQ36686822-02026A6A-1EBE-4BB9-9D20-150C02AEC1F8Q36793727-8A0375E4-F307-4BE9-B12C-C35F1D3DC1E5Q36827287-A8A556BE-070A-4CF3-A1BB-9D13DCC0DB71Q36886361-45141AED-F3EB-4DFF-8EA0-44A7D4CA071F
P2860
Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Predictors and prevalence of p ...... th mutations of the SDHC gene.
@en
Predictors and prevalence of p ...... th mutations of the SDHC gene.
@nl
type
label
Predictors and prevalence of p ...... th mutations of the SDHC gene.
@en
Predictors and prevalence of p ...... th mutations of the SDHC gene.
@nl
prefLabel
Predictors and prevalence of p ...... th mutations of the SDHC gene.
@en
Predictors and prevalence of p ...... th mutations of the SDHC gene.
@nl
P2093
P50
P356
P1476
Predictors and prevalence of p ...... th mutations of the SDHC gene.
@en
P2093
Andrzej Januszewicz
Andrzej Kawecki
Ansgar Berlis
Birke Bausch
Bora E Baysal
Carsten C Boedeker
Catherine Bauters
Christian Pawlu
Clara Fuentes Gomez
European-American Paraganglioma Study Group
P304
P356
10.1001/JAMA.294.16.2057
P407
P577
2005-10-01T00:00:00Z